is janumet a glp-1 and Janumet XR: Side Effects and Their Treatments Janumet Dosage: Strengths, Timing, and
Description
Even after the shortages for both drugs ended as per the FDA, the American Society of Health-System Pharmacists (ASHP), for example, only declared them resolved in a 5 March update

Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy
Despite inherent limitations of observational data and potential for residual confounding, the results from these observational analyses support, in line with RCT findings, combining SGLT2is and GLP-1RAs to reduce cardiovascular events in patients with diabetes in routine clinical care [12, 23, 43, 63]

GLP-1 receptor agonists solve this

only repacking was conducted

Analyses were performed to examine the rate of adverse CVEs using Cox proportional hazards models
